Location:Room Milan, North Hall (Level 1)
ESWL was been the method of first choice in stone treatment for two decades. Endourology has now taken this role of many indications. However, the idea of (almost) no-touch stone disintegration is convincing and new technological developments may turn back the clock.
- Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes in length, followed by 2 minutes for discussion.
Institutes: 1University of Oxford, Oxford Stone Group, Oxford, United Kingdom, 2KU Leuven, Faculty of Medicine, Leuven, Belgium, 3University of Oxford, Medical Sciences Division, Oxford, United Kingdom, 4Philipps-Universität Marburg, Dept. of Urology and Paediatric Urology, Marburg, Germany, 5University of Oxford, Kennedy Institute of Rheumatology, Oxford, United Kingdom
Institutes: 1University Hospital Bern, Dept. of Urology and Nephrology, Bern, Switzerland, 2University Hospital Zürich, Dept. of Urology and Nephrology, Zürich, Switzerland, 3University Hospital Basel, Dept. of Urology and Nephrology, Basel, Switzerland, 4University Hospital Geneva, Dept. of Urology and Nephrology, Geneva, Switzerland, 5University Hospital Lausanne, Dept. of Urology and Nephrology, Lausanne, Switzerland
Institutes: 1University Hospital of Zurich, Dept. of Urology, Zurich, Switzerland, 2University Hospital of Zurich,, Dept. of Pathology of Molecular Pathology, Zurich, Switzerland, 3University Hospital of Zurich, Horten Centre for Patient Oriented Research and Knowledge Transfer, Zurich, Switzerland